Get the Stockscreener App
232.26
2.61%
5.91
After Hours:
232.26
Overview
News
Price History
Option Chain
Financials
Why THC Down?
Discussions
Forecast
Stock Split
Dividend History
Tenet Healthcare Corp stock is traded at $232.26, with a volume of 2.46M.
It is up +2.61% in the last 24 hours and up +16.36% over the past month.
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
See More
Previous Close:
$226.35
Open:
$226.35
24h Volume:
2.46M
Relative Volume:
2.51
Market Cap:
$20.41B
Revenue:
$20.69B
Net Income/Loss:
$2.40B
P/E Ratio:
14.87
EPS:
15.6208
Net Cash Flow:
$1.55B
1W Performance:
+18.52%
1M Performance:
+16.36%
6M Performance:
+36.24%
1Y Performance:
+84.06%
1-Day Range:
$223.80
$235.77
1-Week Range:
$186.50
$235.77
52-Week Range:
$109.82
$235.77
Tenet Healthcare Corp Stock (THC) Company Profile
Name
Tenet Healthcare Corp
Sector
Industry
Phone
469-893-2200
Address
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, UHS, FMS, ENSG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THC
Tenet Healthcare Corp
|
232.26 | 19.89B | 20.69B | 2.40B | 1.55B | 15.62 |
|
HCA
Hca Healthcare Inc
|
535.22 | 118.85B | 75.60B | 7.78B | 7.69B | 28.38 |
|
UHS
Universal Health Services Inc
|
234.05 | 14.45B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.46 | 13.94B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
214.41 | 12.32B | 4.11B | 239.98M | 193.10M | 4.12 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Resumed | Goldman | Buy |
| Jul-28-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| May-29-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-25 | Initiated | Morgan Stanley | Overweight |
| Feb-26-25 | Initiated | TD Cowen | Buy |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-16-24 | Downgrade | Goldman | Buy → Neutral |
| Nov-25-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-22-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-19-23 | Initiated | JP Morgan | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| Mar-29-22 | Initiated | Wells Fargo | Overweight |
| Feb-10-22 | Upgrade | UBS | Neutral → Buy |
| Feb-09-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Feb-09-22 | Upgrade | Truist | Hold → Buy |
| Jan-20-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-24-21 | Initiated | UBS | Neutral |
| Aug-12-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Jul-23-21 | Resumed | Citigroup | Buy |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-03-21 | Resumed | Goldman | Buy |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Jan-05-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-15-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-11-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-26-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-09-19 | Upgrade | UBS | Neutral → Buy |
| Nov-06-19 | Upgrade | Credit Suisse | Neutral → Outperform |
| Aug-14-19 | Resumed | Goldman | Neutral |
| Feb-26-19 | Reiterated | BofA/Merrill | Neutral |
| Jan-14-19 | Initiated | Stephens | Equal-Weight |
| Jan-03-19 | Initiated | Deutsche Bank | Hold |
| Dec-17-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-16-18 | Initiated | UBS | Neutral |
| Jun-29-18 | Downgrade | Jefferies | Buy → Hold |
| Mar-23-18 | Resumed | Mizuho | Buy |
| Jan-30-18 | Resumed | Wells Fargo | Market Perform |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Dec-20-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-19-17 | Reiterated | Mizuho | Neutral |
| Dec-14-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-12-17 | Upgrade | Citigroup | Neutral → Buy |
View All
Tenet Healthcare Corp Stock (THC) Latest News
Jefferies Raises Price Target for Tenet Healthcare (THC) to $265 - GuruFocus
UBS Raises Price Target for Tenet Healthcare (THC) to $288 | THC Stock News - GuruFocus
THC: Keybanc Raises Price Target for Tenet Healthcare to $250 | - GuruFocus
Jefferies raises Tenet Healthcare stock price target to $265 on growth outlook - Investing.com
Tenet Healthcare Corporation (NYSE:THC) Q4 2025 Earnings Call Transcript - Insider Monkey
Tenet Healthcare stock price target raised to $250 from $225 at KeyBanc - Investing.com
THC Q4 Deep Dive: Tech-Driven Efficiency and Ambulatory Expansion Offset Exchange Headwinds - Finviz
Is It Too Late To Consider Tenet Healthcare (THC) After A 79% One Year Surge? - Yahoo Finance
Tenet Healthcare Q4 Earnings Call Highlights - Yahoo Finance
Tenet Healthcare Earnings Call Balances Growth and Risks - TipRanks
Tenet: Q4 Financial Results Overview - Bitget
Tenet Healthcare Corp (THC) Q4 2025 Earnings Call Highlights: St - GuruFocus
Tenet Looks Likely To Fend Off Many Upcoming Headwinds - Morningstar
Tenet Healthcare Expands with $1.9B Conifer Deal and Strong Profit Outlook - StocksToTrade
Tenet Healthcare stock price today: THC jumps 16% after Q4 results, 2026 outlook - TechStock²
Tenet Healthcare’s Strategic Deal With CommonSpirit Boosts Growth Forecast - StocksToTrade
Tenet Healthcare shares steady after strong Q4, upbeat 2026 outlook - AlphaStreet News
Tenet Healthcare stock hits all-time high of 222.83 USD - Investing.com
Tenet Healthcare Quarterly Profit Surges As Hospital, Surgery Demand Grows - Benzinga
Tenet Healthcare Q4 2025 presentation: 13% EBITDA growth, balance sheet strengthens - Investing.com
Tenet Healthcare (THC) Q4 2025 Earnings Transcript - The Globe and Mail
Earnings call transcript: Tenet Healthcare Q4 2025 beats earnings expectations - Investing.com
Tenet Healthcare Q4 Earnings Summary & Key Takeaways - Benzinga
Tenet Healthcare reports Q4 adjusted EPS $4.70, consensus $4.05 - TipRanks
Tenet Healthcare (NYSE:THC) Surprises With Q4 CY2025 Sales - Finviz
Tenet Healthcare (THC) Exceeds Q4 Revenue Expectations - GuruFocus
Tenet Healthcare (THC) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Guggenheim Keeps Their Buy Rating on Tenet Healthcare (THC) - The Globe and Mail
Tenet Healthcare Corp (NYSE:THC) Reports Strong Q4 2025 Earnings Beat and Provides 2026 Outlook - ChartMill
Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook By Investing.com - Investing.com South Africa
Tenet Healthcare Corp. Profit Advances In Q4 - Nasdaq
Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook - Investing.com
Tenet: Q4 Earnings Snapshot - KTEN
Tenet Healthcare earnings beat by $0.68, revenue topped estimates - Investing.com
Tenet Healthcare Corporation Reports Strong Q4 and FY 2025 Results - TradingView
Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook - Yahoo Finance
Will Lower Patient Days Affect Tenet Healthcare's Q4 Earnings? - Finviz
Preview: Tenet Healthcare's Earnings - Benzinga
Tenet Healthcare (THC) Q4 Earnings: What To Expect - Finviz
Tenet Healthcare (THC) Valuation Check After Mixed Short Term Returns And Strong Multi Year Performance - Yahoo Finance
Tenet Healthcare (THC) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Tenet Healthcare Corp (NYSE:THC) Presents a Value Investment Case with Strong Profitability - ChartMill
Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Tenet Healthcare (THC) - The Globe and Mail
Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report? - Finviz
Tenet Healthcare (THC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Finviz
Tenet Healthcare (THC) to Release Earnings on Wednesday - MarketBeat
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC) and Becton Dickinson (BDX) - The Globe and Mail
Where Tenet Healthcare Stands With Analysts - Benzinga
UBS reiterates Buy rating on Tenet Healthcare stock amid Conifer restructuring - Investing.com
THC: RBC Capital Raises Price Target to $253, Affirms Outperform Rating | THC Stock News - GuruFocus
RBC Capital raises Tenet Healthcare stock price target to $253 on strong results - Investing.com Canada
Tenet Healthcare Corp Stock (THC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
1.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):